CCHD PulseOx screening

Newborn Screening

Downloads
Revenue

Description

In 2011, pulse oximetry screening was recommended to improve the detection of critical congenital heart defects in newborns. This application was developed by Children’s Healthcare of Atlanta to aid healthcare professionals in implementing pulse oximetry screening in the newborn nursery. The algorithm is endorsed by the American Academy of Pediatrics and the American Heart Association.
Hide Show More...

Screenshots

CCHD PulseOx screening FAQ

  • Is CCHD PulseOx screening free?

    Yes, CCHD PulseOx screening is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is CCHD PulseOx screening legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does CCHD PulseOx screening cost?

    CCHD PulseOx screening is free.

  • What is CCHD PulseOx screening revenue?

    To get estimated revenue of CCHD PulseOx screening app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Canada yet.
Ratings History

CCHD PulseOx screening Reviews

No Reviews in Canada
App doesn't have any reviews in Canada yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

CCHD PulseOx screening Competitors

Name
Georgia TB Reference Guide
Clinical Guidelines
BiliStop
When to Stop Baby Phototherapy
Prevent Group B Strep(GBS)
iFetal Pro
Guide to Clinical Midwifery
The Efficient Midwife
Perfect OB Tracker
Obstetrics wheel and tracker
First Trimester Bleeding
clinician decision support
ESW Resource for Midwives
Simple Ballard Score
Gestational Age Assessment
GynZone - OBGYNs and midwives

CCHD PulseOx screening Installs

Last 30 days

CCHD PulseOx screening Revenue

Last 30 days

CCHD PulseOx screening Revenue and Downloads

Gain valuable insights into CCHD PulseOx screening performance with our analytics.
Sign up now to access downloads, revenue, and more.